HMC-ACC designated as centre of excellence for Rezum Therapy

The Ambulatory Care Centre at Hamad Medical Corporation (HMC) has been designated as a Centre of Excellence for using Rezum Therapy, a non-surgical procedure to treat benign prostatic hyperplasia.

Dr Khalid al-Rumaihi, head of Urology Department at HMC was also honoured as one of the pioneers in the Middle East and North Africa region in the use of Rezum treatment for patients with an enlarged prostate.The Centre of Excellence is usually awarded to treatment centres that have a high degree of expertise in this world-leading technology while providing effective and lasting treatment. Dr al-Rumaihi has treated more than 150 cases using this technique at the Urology Department of ACC. HMC was designated as a Centre of Excellence out of three centres in the Mena region.The Rezum Treatment takes from 5 to 10 minutes, and the patient can leave the hospital on the same day. “This technique is very safe and 90% of patients do not need to take prostate drugs after undergoing treatment with Rezum technology,” Dr al-Rumaihi added.